Uploaded October 2026 | Updated November 2026, 3 hours ago
Key highlights from today’s FFR Listing Ceremony and Investor Day:
• FFR has officially completed the acquisition of FFAI’s robotics business. All related businesses and assets are now part of FFR.
• FFR is now the first U.S.-listed pure-play company focused on a Four-Core Full-Stack AI ecosystem for humanoid and bionic Embodied AI robotics.
• We officially announced FF OmniMind as the brand name for FF Brain, guided by the philosophy: “One Brain, All Robots; Multi Forms, Multi Capabilities.”
• We expect October sales and shipments to exceed 300 robots, with cumulative sales and shipments expected to exceed 1,100 by month-end. Our full-year 2026 guidance is 2,000 robots sold and shipped, while maintaining positive gross margin.
•The five-year business plan projects 2027 total revenue of approximately $45 million and EAI Device sales of 7,400 units. Over the next five years, the outlook projects cumulative revenue of approximately $1.98 billion and cumulative EAI Device sales of approximately 133,000 units, subject to necessary funding.
Key highlights from today’s FFR Listing Ceremony and Investor Day:
• FFR has officially completed the acquisition of FFAI’s robotics business. All related businesses and assets are now part of FFR.
• FFR is now the first U.S.-listed pure-play company focused on a Four-Core Full-Stack AI ecosystem for humanoid and bionic Embodied AI robotics.
• We officially announced FF OmniMind as the brand name for FF Brain, guided by the philosophy: “One Brain, All Robots; Multi Forms, Multi Capabilities.”
• We expect October sales and shipments to exceed 300 robots, with cumulative sales and shipments expected to exceed 1,100 by month-end. Our full-year 2026 guidance is 2,000 robots sold and shipped, while maintaining positive gross margin.
•The five-year business plan projects 2027 total revenue of approximately $45 million and EAI Device sales of 7,400 units. Over the next five years, the outlook projects cumulative revenue of approximately $1.98 billion and cumulative EAI Device sales of approximately 133,000 units, subject to necessary funding.










